menu search

MNOV / Medicinova stock up on European patent award

Medicinova stock up on European patent award
Medicinova Inc (NASDAQ:MNOV) stock started Wednesday on the front foot boosted by a patent award in Europe. The European Patent Office has given protection to the company's asset MN-001 (tipelukast) for the treatment of scleroderma and/or systemic sclerosis. Read More
Posted: Aug 16 2023, 10:15
Author Name: Proactive Investors
Views: 080268

MNOV News  

Medicinova stock up on European patent award

By Proactive Investors
August 16, 2023

Medicinova stock up on European patent award

Medicinova Inc (NASDAQ:MNOV) stock started Wednesday on the front foot boosted by a patent award in Europe. The European Patent Office has given prote more_horizontal

MediciNova Posts Promising Data From COVID-19 Treatment Candidate

By Benzinga
June 8, 2022

MediciNova Posts Promising Data From COVID-19 Treatment Candidate

MediciNova Inc (NASDAQ: MNOV) says the Phase 2 trial of MN-166 (ibudilast) in hospitalized COVID-19 patients demonstrated significant improvements  more_horizontal


Search within

Pages Search Results: